Silymarin

non-nutrient/non-botanicalsilibinin

What is it

Silymarin is the bioactive flavonolignan complex extracted from milk thistle (Silybum marianum) seeds. It is composed primarily of silybin (also called silibinin), isosilybin, silychristin, and silydianin, with silybin accounting for roughly 60 to 70 percent of total activity.

How it works

Silymarin's proposed hepatoprotective mechanisms include direct antioxidant scavenging of free radicals in liver cells, stabilization of hepatocyte membranes against toxin uptake, stimulation of hepatic protein synthesis and regeneration, and inhibition of pro-fibrotic pathways implicated in chronic liver disease. The most striking acute use is in Amanita phalloides (death cap mushroom) poisoning, where intravenous silybin is part of established treatment protocols in European countries; it works in part by competitively inhibiting hepatic uptake of amatoxins. For chronic liver conditions taken orally, silymarin's effects are more modest because oral bioavailability is poor. Standard silymarin extracts have low absorption (around 23 to 47 percent), undergo extensive first-pass metabolism, and have a short plasma half-life. Phytosomal formulations (silybin bound to phosphatidylcholine, sold as Siliphos) achieve 5 to 10 times higher plasma silybin levels and are preferred for serious therapeutic intent. Effects on liver enzymes and disease markers in chronic conditions are real but typically modest.

Evidence for 6 uses

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

Amanita mushroom poisoning (medical antidote)

Grade B

Good evidence

IV silybin (Legalon SIL) is established in mushroom poisoning protocols in Europe and is increasingly available in the US under expanded access. Hospital-administered medical use.

NAFLD and liver enzyme elevation

Grade C

Moderate evidence

Trials of 420 mg/day or higher have shown reductions in ALT and AST and modest improvements in liver fat in adults with NAFLD. Lifestyle changes remain central.

Alcoholic liver disease

Grade C

Moderate evidence

Mixed results across trials. Some show improvements in liver enzymes and modest survival benefit in cirrhosis; others show no effect. Alcohol cessation is far more important.

Drug-induced liver protection

Grade C

Moderate evidence

Trials of silymarin as adjunct to chemotherapy or antitubercular therapy have shown reductions in liver enzyme elevations in some studies.

Chronic viral hepatitis (B and C)

Grade C

Moderate evidence

Trials have shown variable effects on liver enzymes and quality of life with limited effect on viral load. Modern antivirals are far more effective for the underlying disease.

Type 2 diabetes glycemic control

Grade C

Moderate evidence

Some trials show modest reductions in fasting glucose and HbA1c with silymarin (200 to 600 mg/day) in adults with diabetes. Not a substitute for standard treatment.

3 commercial forms

Standardized silymarin extract (80 percent flavonolignans)

Oral bioavailability of silybin is poor (about 23 to 47 percent absorbed).

The standard consumer form. Most economical but requires higher doses for effect.

Silybin phytosome (Siliphos)

Silybin complexed with phosphatidylcholine; 5 to 10 times higher plasma silybin than standard.

Better-absorbed format. Preferred for serious therapeutic intent.

Silybin alone (high-purity)

More concentrated than total silymarin.

Some products isolate silybin specifically. Higher per-gram activity.

Dosage

Typical doses of standardized silymarin extract are 200 to 600 mg per day, divided into 2 or 3 doses. Trials in chronic liver disease have used 420 to 800 mg/day for 2 to 12 months. Phytosomal formulations use 200 to 400 mg/day for comparable plasma silybin levels. IV silybin doses for mushroom poisoning are much higher and hospital-administered.

When and how to take it

Take silymarin with meals to improve absorption of the fat-soluble flavonolignans. Splitting daily totals (200 to 300 mg twice or three times daily) maintains steadier plasma silybin than a single large dose. Phytosomal formulations require lower doses for equivalent plasma levels. Effects on liver enzymes typically appear over 8 to 12 weeks. Silymarin is not stimulating; evening dosing is fine.

Safety

Silymarin is generally well tolerated. Side effects are uncommon and mild: GI upset (nausea, gas, diarrhea), headache, and rare allergic reactions in people with Asteraceae plant allergies. Long-term safety has been studied up to several years in chronic liver disease trials without major signals. No formal Tolerable Upper Intake Level has been established. Silymarin has theoretical mild estrogenic effects, relevant in hormone-sensitive cancers. Pregnancy and breastfeeding have limited data.

Who should be cautious

Avoid with Asteraceae plant allergies (ragweed, daisies, chrysanthemums). Use cautiously with hormone-sensitive cancers, on hepatically metabolized medications, or with diabetes medications. Coordinate with prescribers, especially for warfarin, statins, and chemotherapy. Pregnancy and breastfeeding: consult clinician. Children should not use without specialist guidance.

Interactions

Silymarin affects CYP450 enzymes (particularly CYP2C9 and CYP3A4), potentially altering metabolism of many drugs including warfarin, statins, certain antipsychotics, and chemotherapy agents. May enhance the effects of antidiabetic medications. Theoretical estrogenic activity may interact with hormone-sensitive cancer treatments. Combined with hepatically metabolized drugs, may alter pharmacokinetics either by inhibition (raising drug levels) or by enzyme induction depending on the specific drug and dose.

Frequently asked questions

Is silymarin the same as milk thistle?⌄

Silymarin is the active flavonolignan complex extracted from milk thistle seeds. Milk thistle products are typically standardized to a specific silymarin content (often 80 percent). When you take a silymarin supplement, you're effectively taking a concentrated form of the active part of milk thistle.

What's the difference between silymarin and silybin?⌄

Silymarin is the complex of related flavonolignans (silybin, isosilybin, silychristin, silydianin). Silybin is the single most active component, accounting for 60 to 70 percent of silymarin's activity. Some products isolate silybin specifically; most contain the full silymarin complex.

Why is silymarin absorbed so poorly?⌄

Silybin is poorly water-soluble and is rapidly conjugated and excreted by the liver after absorption. The result is low and brief plasma levels. Phytosomal formulations (silybin + phosphatidylcholine) substantially improve absorption.

How long until I see effects?⌄

Changes in liver enzymes typically appear over 8 to 12 weeks of consistent daily dosing. Don't expect immediate effects.

Can silymarin reverse liver damage?⌄

Silymarin may reduce liver enzyme markers of ongoing damage and modestly support liver function, but it does not reverse established cirrhosis or chronic damage. Stopping the underlying insult (alcohol, hepatotoxic drugs, viral infection) is far more important than any supplement.

References

  • Wikidata: Silymarin — Wikidata link

Track Silymarin with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you're pregnant, breastfeeding, on medications, or managing a chronic condition.